A metabolite da ake samu daga ruwan itacen rumman (pomegranate) da kuma wani polyphenol na shayi mai kore sun shiga cikin wani gwajin berayen da aka yi wa alamar Alzheimer, kuma mitochondria sun fara amsawa. Wannan shi ne taƙaitaccen bayani daga wani sabon takarda da aka wallafa a Mitochondrion (2026). Bayanin yana da tsawo, amma an gabatar da shi a matsayin sharhi kan yiwuwar ƙara sinadarai.
Gaba ɗaya a farko: wannan bincike ne na berayen. Dabbobin sun karɓi allura, ba ƙwayoyin ƙara ba. Marubutan kansu sun nuna cewa akwai muhimman tambayoyi da ke buƙatar amsa.
Abin da masu binciken suka yi
Wani ƙungiya daga Texas Tech University Health Sciences Center da AbSynaptex LLC sun yi nazari kan berayen humanized amyloid‑β knock‑in (hAbKI), wani samfur da ake amfani da shi a binciken cutar Alzheimer. Kwayoyin biyu da aka yi amfani da su sune:
- Urolithin A (UA): a cikin takardar an bayyana shi a matsayin metabolite da ke ƙarfafa mitophagy – hanyar da ƙwayar halitta ke amfani da ita don kawar da mitochondria da suka lalace.
- Epigallocatechin‑3‑gallate (EGCG): polyphenol na shayi mai kore da marubutan ke danganta shi da ƙarfi anti‑oxidant, anti‑inflammatory da anti‑amyloidogenic.
Berayen sun fara samun magani a watanni uku na ƙuruciya. Sun karɓi ko dai UA (2.5 mg/kg) ko UA da EGCG (25 mg/kg) ta allurar intraperitoneal, sau uku a mako, na tsawon watanni huɗu. Ƙungiyar ta auna nau’ikan gwaje‑gwaje da yawa a watan bakwai.
Sauye‑sauyen da aka gani a berayen da aka magance
Marubutan sun ba da rahoton canje‑canje a fannoni da dama na ilimin mitochondria.
Fission da fusion. Jimillar fission proteins Drp1 da Fis1 ta ragu, yayin da jimillar fusion proteins Mfn1, Mfn2 da Opa1 kuwa ta ƙaru. An tabbatar da waɗannan canje‑canje ta hanyar immunoblotting.
Biogenesis. Kwayoyin da ke da alaka da ƙirƙirar sabbin mitochondria – PGC‑1α, Nrf1 da TFAM – sun tashi.
Alamomin mitophagy da autophagy. Matakan PINK1, Parkin, ATG5, LC3B, Beclin‑1 da BCL2 sun ƙaru.
Tsari da makamashi. Microscope na electron ya nuna mitochondria mafi tsayi da ƙananan fashe‑fashe. Matakan ATP na mitochondria sun ƙaru, yayin da hydrogen peroxide da 4‑hydroxynonenal (alamomin damuwar oxidative) suka ragu.
Alamomin ƙwayoyin kwakwalwa. Dukkan magungunan sun haifar da:
- ƙaruwa a matakan synaptic da dendritic
- ragin Iba1 da GFAP (alamomin da ke nuna aikin glial)
- ƙaruwa a NeuN (alama ta neuron)
- ragin Aβ40 da Aβ42 masu narkewa
- kyakkyawan sakamako a wasu gwaje‑gwajen ɗabi'a
Inda haɗin ya fi fice
A fannoni da yawa na mitochondria da na ƙwayoyin kwakwalwa, amsar ta fi ƙarfi tare da UA da EGCG fiye da maganin da aka yi shi kadai. Marubutan sun kammala da cewa UA na da tasiri a kan abubuwa da dama na kulawar ingancin mitochondria a cikin waɗannan berayen. Sun kuma nuna cewa ƙara EGCG yana da alaƙa da faɗaɗɗen ingantaccen yanayin mitochondria da ƙwayoyin kwakwalwa.
Kalmar “ya danganta da” ba tana nufin “ya haifar da” ba, kuma takardar ba ta ikirarin cewa haɗin yana da tabbacin mafi alheri a kowane mataki ba.
Matsaloli: abin da binciken bai bayyana ba
Marubutan sun bayyana a fili cewa akwai buƙatar ci gaba da aiki don:
- Fassara takamaiman rawar EGCG. Tsarin yana nuna haɗin ya fi tasiri, amma ba ya raba a fili abin da EGCG ke yi da kansa.
- Auna flux ɗin mitophagy kai tsaye. An auna alamomin mitophagy da autophagy, amma hakan ba ya nufin an ga tsaftacewa tana gudana da sauri.
- Auna numfashin mitochondria kai tsaye. An auna matakan ATP, amma ba a auna respiration ba.
Ƙuntatawa na tsarin
- Samfurin dabbobi kawai. Berayen da aka ƙirƙira don amyloid‑β ba za su iya wakiltar cikakken yanayin cutar Alzheimer a mutum ba.
- Hanyar allura. Allurar intraperitoneal ba ta nuna abin da ke faruwa idan an sha kwayar a cikin abinci ko jini.
- Lokaci ƙanƙanta, farawa da wuri. Magani ya fara a watanni 3 kuma ya ƙare a watanni 7. Takardar ba ta nuna ko sakamakon zai ci gaba a manyan dabbobi ko bayan cutar ta fara ba.
- Mafi yawan alamomin ƙwayoyin. Yawancin sakamakon suna a kan furotin da alamu, waɗanda muhimmai ne amma ba su zama alamomin asibiti ba.
Abubuwan da za a iya ɗauka a aikace
Kima. Ba a ƙayyade wani kima na mutum ba don wannan haɗin. Kima na berayen (2.5 mg/kg UA da 25 mg/kg EGCG, an allura) ba za a maida su zuwa tsarin ƙara sinadarai ba. Don ba da misali, nazarin mutane kan urolithin A na baki ya yi amfani da kusan 500‑1,000 mg a kowace rana. Wadannan nazarce‑nazarce ba su gwada haɗin ba kuma ba su nuna cewa yana aiki ga canjin mitochondria da ke da alaƙa da Alzheimer.
Lokaci. A berayen, an yi magani sau uku a mako na watanni huɗu, da wuri. Ko irin wannan tsari ko lokacin zai yi ma’ana a mutane ba a sani ba.
Waɗanda za su amfana. A halin yanzu, yana ga masu bincike ne kawai. Babu wani abu a cikin wannan takardar da ke tallafawa amfani da UA ko EGCG don hana ko warkar da Alzheimer. Duk wanda ke da cuta ko ke damuwa da mantuwa ya kamata ya tuntuɓi likita kafin ya ƙara sinadarai. A matsayin ƙarin bayani, wasu fitarwa na shayi mai kore na iya haifar da matsalolin hanta a wasu mutane, don haka neman shawarwarin likita yana da mahimmanci.
Dalilin da ya sa har yanzu yake da muhimmanci a biye da shi
Rashin aiki na mitochondria da raunin kulawar inganci suna ƙara bayyana a matsayin abubuwan da ke taimakawa cutar Alzheimer. Haɗin da ke shafar fusion, biogenesis, hanyoyin da suka danganci mitophagy da oxidative stress lokaci guda yana da ban sha'awa a matsayin ra'ayi. Wannan takarda ta ƙara wani siginar pre‑clinical mai ma’ana. Matakan gaba sune waɗanda marubuta suka ambata: auna flux ɗin mitophagy da respiration kai tsaye, da ware rawar EGCG. Har sai an yi hakan, a ɗauke shi a matsayin wani kyakkyawan binciken beraye, ba a matsayin tsarin magani ba.
Source: Kshirsagar S, et al. Urolithin A plus EGCG enhances mitophagy associated pathways, mitochondrial dynamics, and bioenergetic function in humanized amyloid‑β knock‑in mice. Mitochondrion. 2026;92:102237. doi:10.1016/j.mito.2026.102237. PMID: 43009032.